Memo Therapeutics raised €35M in a Series B round in Feb 2022. The company is based in Zurich, Switzerland. Investors in the round: Adjuvant Capital, Fresenius Medical Care Ventures, GF Group Holding and 4 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
